Save information for later
Sign Up

Learn About Mevalonate Kinase Deficiency

What is the definition of Mevalonate Kinase Deficiency?

Mevalonate kinase deficiency is a condition characterized by recurrent episodes of fever, which typically begin during infancy. Each episode of fever lasts about 3 to 6 days, and the frequency of the episodes varies among affected individuals. In childhood the fevers seem to be more frequent, occurring as often as 25 times a year, but as the individual gets older the episodes occur less often.

What are the causes of Mevalonate Kinase Deficiency?

Mutations in the MVK gene cause mevalonate kinase deficiency. The MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme is involved in the production of cholesterol, which is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

How prevalent is Mevalonate Kinase Deficiency?

More than 200 people with mevalonate kinase deficiency have been reported worldwide; the majority of these individuals have HIDS.

Is Mevalonate Kinase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Mevalonate Kinase Deficiency Local Doctors?
Experienced in Mevalonate Kinase Deficiency
Rheumatology
Experienced in Mevalonate Kinase Deficiency
Rheumatology

UT Physicians

6410 Fannin St, Suite 604, 
Houston, TX 
 (41.4 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Bochra Jandali is a Rheumatologist in Houston, Texas. Dr. Jandali and is rated as an Experienced provider by MediFind in the treatment of Mevalonate Kinase Deficiency. Her top areas of expertise are Mevalonate Kinase Deficiency, Systemic Sclerosis (SSc), Scleroderma, and Polymyositis. Dr. Jandali is currently accepting new patients.

Experienced in Mevalonate Kinase Deficiency
Internal Medicine
Experienced in Mevalonate Kinase Deficiency
Internal Medicine

Privia Medical Group Gulf Coast PLLC

7900 Fannin St, Suite 4000, 
Houston, TX 
 (43.0 mi)
Languages Spoken:
English
Accepting New Patients

Mark Florian is an Internal Medicine provider in Houston, Texas. Dr. Florian and is rated as an Experienced provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are High Cholesterol, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Florian is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Mevalonate Kinase Deficiency
Internal Medicine
Experienced in Mevalonate Kinase Deficiency
Internal Medicine

Ipc Healthcare Services Of Texas PLLC

2400 Round Rock Ave, 
Round Rock, TX 
 (135.3 mi)
Languages Spoken:
English, Burmese, Malayalam, Spanish
Accepting New Patients

Aneesh George is an Internal Medicine provider in Round Rock, Texas. Dr. George and is rated as an Experienced provider by MediFind in the treatment of Mevalonate Kinase Deficiency. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Sepsis, Necrosis, and Ureteroscopy. Dr. George is currently accepting new patients.

What are the latest Mevalonate Kinase Deficiency Clinical Trials?
An Exploratory Study of the Genetics, Pathophysiology, and Natural History of Autoinflammatory Diseases

Summary: This study is designed to explore the genetics and pathophysiology of diseases presenting with intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseases. The following individuals may be eligible for this natural history study: 1) patients with known or suspected familial Mediterranean fever, TRAPS, hyper-IgD syndrome or related disorders; 2) relat...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency, MVK Deficiency (hyperIgD Syndrome)

Summary: Mevalonate kinase deficiency (HyperIgD syndrome, HIDS) is an inborn error of immunity caused by a block in the mevalonate pathway. The subsequent lack of isoprenoids with antiinflammatory properties might contribute to the autoinflammatory nature of the disease. A pilot study aims to verify the safety and efficacy of the dietary supplement Geranylgeraniol, aiming at a mitigation of isoprenoids def...

Who are the sources who wrote this article ?

Published Date: October 01, 2018
Published By: National Institutes of Health